Please enable JavaScript to continue using this application.

Compare $ABEO vs $BNTC | Chartloom

Compare

$ABEO vs $BNTC

Abeona Therapeutics Inc · Benitec Biopharma Inc

ABEO

Abeona Therapeutics Inc

BNTC

Benitec Biopharma Inc

Compare $ABEO vs $BNTC

Comparing Abeona Therapeutics Inc and Benitec Biopharma Inc

ABEOAbeona Therapeutics Inc

BNTCBenitec Biopharma Inc

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

BNTC

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

BNTC

Benitec Biopharma Inc

Market Cap

ABEO$282M

BNTC$305M

Enterprise Value

ABEO$240M

BNTC$125M

Price

ABEO$4.94

BNTC$8.87

P/E Ratio

ABEON/A

BNTCN/A

P/S Ratio

ABEO11.03x

BNTC4,474.96x

EV/Sales

ABEO9.42x

BNTC1,903.93x

EV/EBITDA

ABEO3.95x

BNTC0.00x

P/B Ratio

ABEO2.25x

BNTC1.77x

P/FCF Ratio

ABEON/A

BNTCN/A

EV/FCF

ABEO-2.95x

BNTC-7.50x

PEG Ratio

ABEON/A

BNTCN/A

Forward P/E (NTM)

ABEON/A

BNTCN/A

Forward P/S (NTM)

ABEO3.20x

BNTCN/A

Revenue (TTM)

ABEO$26M

BNTC$0

Revenue Growth (YoY)

ABEO6280.0%

BNTCN/A

Forward Rev Growth

ABEO131.0%

BNTC13.8%

Gross Margin (TTM)

ABEO67.1%

BNTC100.0%

Operating Margin (TTM)

ABEO0.0%

BNTC0.0%

EBITDA Margin (TTM)

ABEO-316.6%

BNTC0.0%

Net Margin (TTM)

ABEO-246.4%

BNTC0.0%

FCF Margin (TTM)

ABEO-319.5%

BNTCN/A

Net Income (TTM)

ABEO$-63M

BNTC$-33M

FCF (TTM)

ABEO$-82M

BNTC$-17M

EPS (TTM)

ABEO-$1.10

BNTC$0.00

ROE (TTM)

ABEO-4169.0%

BNTC-3482.0%

ROA (TTM)

ABEO-3036.0%

BNTC-3411.0%

ROIC (TTM)

ABEO-3719.0%

BNTC-3482.0%

Cash

ABEO$56M

BNTC$180M

Debt

ABEO$15M

BNTC$0

Net Cash/Debt

ABEO$41M

BNTC$180M

Current Ratio (TTM)

ABEO6.63x

BNTC34.00x

Quick Ratio (TTM)

ABEO6.32x

BNTC33.70x

Debt/Equity (TTM)

ABEO0.12x

BNTC0.00x

Debt/Assets (TTM)

ABEO0.0%

BNTC0.0%

Interest Coverage (TTM)

ABEON/A

BNTCN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

BNTC0.00x

Beta

ABEO1.45

BNTC0.23

52W Performance

ABEO-10.8%

BNTC-37.1%

YTD Performance

ABEO-7.0%

BNTC-29.5%

% from 52W High

ABEO-35.4%

BNTC-47.1%

% from 52W Low

ABEO23.5%

BNTC4.1%

Asset Turnover (TTM)

ABEO0.13x

BNTC0.01x

FCF Yield (TTM)

ABEO-29.0%

BNTC-5.5%

Earnings Yield (TTM)

ABEO-22.3%

BNTC-10.7%

Dividend Yield (TTM)

ABEON/A

BNTCN/A

Rule of 40

ABEO5,960.5

BNTC0.0

EV/GP/RG

ABEO0.04

BNTCN/A

Ticker research

View ABEO research View BNTC research

Metric	ABEO Abeona Therapeutics Inc	BNTC Benitec Biopharma Inc
Market & Valuation
Market Cap	$282M	$305M
Enterprise Value	$240M	$125M
Price	$4.94	$8.87
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	4,474.96x
EV/Sales	9.42x	1,903.93x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	1.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	13.8%
Profitability
Gross Margin (TTM)	67.1%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-33M
FCF (TTM)	$-82M	$-17M
EPS (TTM)	-$1.10	$0.00
ROE (TTM)	-4169.0%	-3482.0%
ROA (TTM)	-3036.0%	-3411.0%
ROIC (TTM)	-3719.0%	-3482.0%
Financial Health
Cash	$56M	$180M
Debt	$15M	$0
Net Cash/Debt	$41M	$180M
Current Ratio (TTM)	6.63x	34.00x
Quick Ratio (TTM)	6.32x	33.70x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.23
52W Performance	-10.8%	-37.1%
YTD Performance	-7.0%	-29.5%
% from 52W High	-35.4%	-47.1%
% from 52W Low	23.5%	4.1%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.01x
FCF Yield (TTM)	-29.0%	-5.5%
Earnings Yield (TTM)	-22.3%	-10.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View BNTC research

Valuation

P/S Ratio

ABEO

11.03x

BNTC

4,474.96x

EV/FCF

BNTC

-7.50x

ABEO

-2.95x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

Forward Revenue Growth

ABEO

131.0%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

ABEO

67.1%

ROE

BNTC

-3482.0%

ABEO

-4169.0%

FCF Yield %

BNTC

-5.5%

ABEO

-29.0%

52-Week Performance

ABEO

-10.8%

BNTC

-37.1%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

BNTC

Benitec Biopharma Inc

Market Cap

ABEO$282M

BNTC$305M

Enterprise Value

ABEO$240M

BNTC$125M

Price

ABEO$4.94

BNTC$8.87

P/E Ratio

ABEON/A

BNTCN/A

P/S Ratio

ABEO11.03x

BNTC4,474.96x

EV/Sales

ABEO9.42x

BNTC1,903.93x

EV/EBITDA

ABEO3.95x

BNTC0.00x

P/B Ratio

ABEO2.25x

BNTC1.77x

P/FCF Ratio

ABEON/A

BNTCN/A

EV/FCF

ABEO-2.95x

BNTC-7.50x

PEG Ratio

ABEON/A

BNTCN/A

Forward P/E (NTM)

ABEON/A

BNTCN/A

Forward P/S (NTM)

ABEO3.20x

BNTCN/A

Revenue (TTM)

ABEO$26M

BNTC$0

Revenue Growth (YoY)

ABEO6280.0%

BNTCN/A

Forward Rev Growth

ABEO131.0%

BNTC13.8%

Gross Margin (TTM)

ABEO67.1%

BNTC100.0%

Operating Margin (TTM)

ABEO0.0%

BNTC0.0%

EBITDA Margin (TTM)

ABEO-316.6%

BNTC0.0%

Net Margin (TTM)

ABEO-246.4%

BNTC0.0%

FCF Margin (TTM)

ABEO-319.5%

BNTCN/A

Net Income (TTM)

ABEO$-63M

BNTC$-33M

FCF (TTM)

ABEO$-82M

BNTC$-17M

EPS (TTM)

ABEO-$1.10

BNTC$0.00

ROE (TTM)

ABEO-4169.0%

BNTC-3482.0%

ROA (TTM)

ABEO-3036.0%

BNTC-3411.0%

ROIC (TTM)

ABEO-3719.0%

BNTC-3482.0%

Cash

ABEO$56M

BNTC$180M

Debt

ABEO$15M

BNTC$0

Net Cash/Debt

ABEO$41M

BNTC$180M

Current Ratio (TTM)

ABEO6.63x

BNTC34.00x

Quick Ratio (TTM)

ABEO6.32x

BNTC33.70x

Debt/Equity (TTM)

ABEO0.12x

BNTC0.00x

Debt/Assets (TTM)

ABEO0.0%

BNTC0.0%

Interest Coverage (TTM)

ABEON/A

BNTCN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

BNTC0.00x

Beta

ABEO1.45

BNTC0.23

52W Performance

ABEO-10.8%

BNTC-37.1%

YTD Performance

ABEO-7.0%

BNTC-29.5%

% from 52W High

ABEO-35.4%

BNTC-47.1%

% from 52W Low

ABEO23.5%

BNTC4.1%

Asset Turnover (TTM)

ABEO0.13x

BNTC0.01x

FCF Yield (TTM)

ABEO-29.0%

BNTC-5.5%

Earnings Yield (TTM)

ABEO-22.3%

BNTC-10.7%

Dividend Yield (TTM)

ABEON/A

BNTCN/A

Rule of 40

ABEO5,960.5

BNTC0.0

EV/GP/RG

ABEO0.04

BNTCN/A

Ticker research

View ABEO research View BNTC research

Metric	ABEO Abeona Therapeutics Inc	BNTC Benitec Biopharma Inc
Market & Valuation
Market Cap	$282M	$305M
Enterprise Value	$240M	$125M
Price	$4.94	$8.87
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	4,474.96x
EV/Sales	9.42x	1,903.93x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	1.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-7.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	13.8%
Profitability
Gross Margin (TTM)	67.1%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-33M
FCF (TTM)	$-82M	$-17M
EPS (TTM)	-$1.10	$0.00
ROE (TTM)	-4169.0%	-3482.0%
ROA (TTM)	-3036.0%	-3411.0%
ROIC (TTM)	-3719.0%	-3482.0%
Financial Health
Cash	$56M	$180M
Debt	$15M	$0
Net Cash/Debt	$41M	$180M
Current Ratio (TTM)	6.63x	34.00x
Quick Ratio (TTM)	6.32x	33.70x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.23
52W Performance	-10.8%	-37.1%
YTD Performance	-7.0%	-29.5%
% from 52W High	-35.4%	-47.1%
% from 52W Low	23.5%	4.1%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.01x
FCF Yield (TTM)	-29.0%	-5.5%
Earnings Yield (TTM)	-22.3%	-10.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View BNTC research